Company Research Report: MiWEndo Solutions

Company Overview

• Name: MiWEndo Solutions

• Mission: The company's mission is to bring innovative technologies to the practical diagnosis of diseases related to tumor processes, with an initial focus on developing and launching a novel endoscopy accessory medical device based on microwave technology targeting early detection of colorectal cancer to reduce its incidence and mortality.

• Founded: The company was founded on September 18, 2019.

• Founders: The company is a spinoff involving multiple institutions: Universitat Pompeu Fabra, Universitat Politècnica de Catalunya, Hospital Clínic de Barcelona, and Institució Catalana de Recerca i Estudis Avançats.

• Key People:

• Ignasi Belda, PhD. (Co-Founder & CEO)

• Glòria Fernàndez Esparrach, MD, PhD. (Co-Founder & CMO)

• Marta Guardiola, PhD. (Co-Founder & CTO)

• Headquarters: AV. Pau Casals 4 5º 1a | 08021 Barcelona, Spain.

• Number of Employees: Approximately 20 employees.

• Revenue: No information is available

• Known For: MiWEndo Solutions is known for integrating microwave technology with colonoscopy to improve the prevention, diagnosis, and knowledge of colorectal cancer.

Products

Product: MiWEndo

• Description: MiWEndo is a low-cost and safe electromagnetic accessory designed to be attached at the tip of a conventional colonoscope.

• Key Features:

• Automates polyp detection by emitting an alarm when a polyp is sensed.

• Increases the field of view to 360º.

• Differentiates between malignant and benign tissues without altering current clinical practice.

• No ionizing radiation is used.

Recent Developments

• Research and Publications:

1. Publication of a paper on preclinical evaluation of a microwave-based accessory device for colonoscopy in an in vivo porcine model with colorectal polyps, dated October 25, 2023.
2. Release of research detailing "Movement tracking and false positive reduction method for microwave colonoscopy systems" published in the IEEE Journal of Electromagnetics, RF, and Microwaves in Medicine and Biology.

• Awards and Recognition:

• MiWEndo Solutions has been the recipient of several awards, such as the SME of the Year Award, and its CTO, Marta Guardiola, received the Juan López de Peñalver medal from the Royal Academy of Engineering.

• Finalist in the Women Startup Awards 2024 in the Ideation category for Marta Guardiola.

• Partnerships and Collaborations:

• MiWEndo is actively collaborating with top-tier clinical partners for pivotal clinical trials as part of its commitment to innovative solutions for cancer detection.

• The company collaborates with healthcare professionals and industry leaders to enhance patient outcomes.

• Clinical Trials and Studies:

• Initiation of a pivotal clinical study involving 50 patients to advance their device towards regulatory market release in the EU and US.

• Patents: The company holds several patents, for example, EP 3 195 786 A1, JP6815405 (B2), and various others across jurisdictions like ES, IT, FR, DE, and GB.

This detailed report provides an overview of MiWEndo Solutions, including its mission, key figures, products, and recent advancements in the medical equipment manufacturing sector, particularly in colorectal cancer detection technology.